Stem Cell Reviews and Reports

, Volume 9, Issue 4, pp 493–504 | Cite as

Differentiation and Transplantation of Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells

  • Samira Asgari
  • Mohsen Moslem
  • Kamran Bagheri-Lankarani
  • Behshad Pournasr
  • Maryam Miryounesi
  • Hossein BaharvandEmail author


The generation of human induced pluripotent stem cells (hiPSCs) with a high differentiation potential provided a new source for hepatocyte generation not only for drug discovery and in vitro disease models, but also for cell replacement therapy. However, the reported hiPSC-derived hepatocyte-like cells (HLCs) were not well characterized and their transplantation, as the most promising clue of cell function was not reported. Here, we performed a growth factor-mediated differentiation of functional HLCs from hiPSCs and evaluated their potential for recovery of a carbon tetrachloride (CCl4)-injured mouse liver following transplantation. The hiPSC-derived hepatic lineage cells expressed hepatocyte-specific markers, showed glycogen and lipid storage activity, secretion of albumin (ALB), alpha-fetoprotein (AFP), urea, and CYP450 metabolic activity in addition to low-density lipoprotein (LDL) and indocyanin green (ICG) uptake. Similar results were observed with human embryonic stem cell (hESC)-derived HLCs. The transplantation of hiPSC-HLCs into a CCl4-injured liver showed incorporation of the hiPSC-HLCs into the mouse liver which resulted in a significant enhancement in total serum ALB after 1 week. A reduction of total serum LDH and bilirubin was seen when compared with the control and sham groups 1 and 5 weeks post-transplantation. Additionally, we detected human serum ALB and ALB-positive transplanted cells in both the host serum and livers, respectively, which showed functional integration of transplanted cells within the mouse livers. Therefore, our results have opened up a proof of concept that functional HLCs can be generated from hiPSCs, thus improving the general condition of a CCl4-injured mouse liver after their transplantation. These results may bring new insights in the clinical applications of hiPSCs once safety issues are overcome.


Human induced pluripotent stem cells Human embryonic stem cells Hepatocytes Transplantation 



This study was funded by a grant provided from Royan Institute and the Iranian Council of Stem Cell Technology. We also thank Mehran Rezaei, Arefeh Ghodsizadeh, Zahra Farzaneh and Abbass Piriayei for their critical comments. Additionally, we would like to thank the Electron Microscopy Lab at the University of Tehran.

Conflict of interest

None of the authors have any conflicts of interest to disclose and all authors support submission to this journal.

Supplementary material

12015_2011_9330_MOESM1_ESM.docx (39 kb)
Supplementary Table 1 Primary and secondary antibodies used for immunofluorescence staining and flow cytometry. (DOCX 39 kb)
12015_2011_9330_MOESM2_ESM.docx (39 kb)
Supplementary Table 2 List of primers used in this study. (DOCX 38 kb)


  1. 1.
    Mazaris, E. M., Roussos, C. T., & Papalois, V. E. (2005). Hepatocyte transplantation: a review of worldwide clinical developments and experiences. Experimental and Clinical Transplantation, 3, 306–315.PubMedGoogle Scholar
  2. 2.
    Miro, J. M., Laguno, M., Moreno, A., & Rimola, A. (2006). Management of end stage liver disease (ESLD): what is the current role of orthotopic liver transplantation (OLT)? Journal of Hepatology, 44, S140–145.PubMedCrossRefGoogle Scholar
  3. 3.
    Lorenzini, S., Isidori, A., Catani, L., et al. (2008). Stem cell mobilization and collection in patients with liver cirrhosis. Alimentary Pharmacology and Therapeutics, 27, 932–939.PubMedCrossRefGoogle Scholar
  4. 4.
    Lee, S. W., Wang, X., Chowdhury, N. R., & Roy-Chowdhury, J. (2004). Hepatocyte transplantation: state of the art and strategies for overcoming existing hurdles. Annals of Hepatology, 3, 48–53.PubMedGoogle Scholar
  5. 5.
    Asgari, S., Pournasr, B., Salekdeh, G. H., Ghodsizadeh, A., Ott, M., & Baharvand, H. (2010). Induced pluripotent stem cells: a new era for hepatology. Journal of Hepatology, 53, 738–751.PubMedCrossRefGoogle Scholar
  6. 6.
    Pournasr, B., Farzaneh, Z., Shahsanvani, M., & Baharvand, H. (2010). Liver development and In vitro differentiation of embryonic stem cells to hepatocytes. Yakhteh Medical Journal (Cell Journal), 11, 348–373.Google Scholar
  7. 7.
    Takahashi, K., Tanabe, K., Ohnuki, M., et al. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131, 861–872.PubMedCrossRefGoogle Scholar
  8. 8.
    Yu, J., Vodyanik, M. A., Smuga-Otto, K., et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science, 318, 1917–1920.PubMedCrossRefGoogle Scholar
  9. 9.
    Liu, H., Ye, Z., Kim, Y., Sharkis, S., & Jang, Y. Y. (2010). Generation of endoderm-derived human induced pluripotent stem cells from primary hepatocytes. Hepatology, 51, 1810–1819.PubMedCrossRefGoogle Scholar
  10. 10.
    Touboul, T., Hannan, N. R., Corbineau, S., et al. (2010). Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development. Hepatology, 51, 1754–1765.PubMedCrossRefGoogle Scholar
  11. 11.
    Si-Tayeb, K., Noto, F. K., Nagaoka, M., et al. (2010). Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology, 51, 297–305.PubMedCrossRefGoogle Scholar
  12. 12.
    Song, Z., Cai, J., Liu, Y., et al. (2009). Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells. Cell Research, 19, 1233–1242.PubMedCrossRefGoogle Scholar
  13. 13.
    Sullivan, G. J., Hay, D. C., Park, I. H., et al. (2010). Generation of functional human hepatic endoderm from human induced pluripotent stem cells. Hepatology, 51, 329–335.PubMedCrossRefGoogle Scholar
  14. 14.
    Totonchi, M., Taei, A., Seifinejad, A., et al. (2010). Feeder- and serum-free establishment and expansion of human induced pluripotent stem cells. International Journal of Developmental Biology, 54, 877–886.PubMedCrossRefGoogle Scholar
  15. 15.
    Baharvand, H., Ashtiani, S. K., Taee, A., et al. (2006). Generation of new human embryonic stem cell lines with diploid and triploid karyotypes. Development, Growth & Differentiation, 48, 117–128.CrossRefGoogle Scholar
  16. 16.
    Pakzad, M., Totonchi, M., Taei, A., Seifinejad, A., Hassani, S. N., & Baharvand, H. (2010). Presence of a ROCK inhibitor in extracellular matrix supports more undifferentiated growth of feeder-free human embryonic and induced pluripotent stem cells upon passaging. Stem Cell Reviews, 6, 96–107.PubMedCrossRefGoogle Scholar
  17. 17.
    Tzanakakis, E. S., Hsiao, C. C., Matsushita, T., Remmel, R. P., & Hu, W. S. (2001). Probing enhanced cytochrome P450 2B1/2 activity in rat hepatocyte spheroids through confocal laser scanning microscopy. Cell Transplantation, 10, 329–342.PubMedGoogle Scholar
  18. 18.
    Piryaei, A., Valojerdi, M. R., Shahsavani, M., & Baharvand, H. (2011). Differentiation of bone marrow-derived mesenchymal stem cells into hepatocyte-like cells on nanofibers and their transplantation into a carbon tetrachloride-induced liver fibrosis model. Stem Cell Reviews, 7, 103–118.PubMedCrossRefGoogle Scholar
  19. 19.
    Marumoto, Y., Terai, S., Urata, Y., et al. (2008). Continuous high expression of XBP1 and GRP78 is important for the survival of bone marrow cells in CCl4-treated cirrhotic liver. Biochemical and Biophysical Research Communications, 367, 546–552.PubMedCrossRefGoogle Scholar
  20. 20.
    Sakaida, I., Terai, S., Yamamoto, N., et al. (2004). Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice. Hepatology, 40, 1304–1311.PubMedCrossRefGoogle Scholar
  21. 21.
    Terai, S., Sakaida, I., Yamamoto, N., et al. (2003). An in vivo model for monitoring trans-differentiation of bone marrow cells into functional hepatocytes. Journal of Biochemistry, 134, 551–558.PubMedCrossRefGoogle Scholar
  22. 22.
    Mfopou, J. K., & Bouwens, L. (2008). Hedgehog signals in pancreatic differentiation from embryonic stem cells: revisiting the neglected. Differentiation, 76, 107–117.PubMedCrossRefGoogle Scholar
  23. 23.
    Osafune, K., Caron, L., Borowiak, M., et al. (2008). Marked differences in differentiation propensity among human embryonic stem cell lines. Nature Biotechnology, 26, 313–315.PubMedCrossRefGoogle Scholar
  24. 24.
    Kim, D. S., Lee, J. S., Leem, J. W., et al. (2010). Robust enhancement of neural differentiation from human ES and iPS cells regardless of their innate difference in differentiation propensity. Stem Cell Reviews, 6, 270–281.PubMedCrossRefGoogle Scholar
  25. 25.
    Rashid, S. T., Corbineau, S., Hannan, N., et al. (2010). Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. The Journal of Clinical Investigation, 120, 3127–3136.PubMedCrossRefGoogle Scholar
  26. 26.
    Ghodsizadeh, A., Taei, A., Totonchi, M., et al. (2010). Generation of liver disease-specific induced pluripotent stem cells along with efficient differentiation to functional hepatocyte-like cells. Stem Cell Reviews, 6, 622–632.PubMedCrossRefGoogle Scholar
  27. 27.
    Basma, H., Soto-Gutierrez, A., Yannam, G. R., et al. (2009). Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. Gastroenterology, 136, 990–999.PubMedCrossRefGoogle Scholar
  28. 28.
    Agarwal, S., Holton, K. L., & Lanza, R. (2008). Efficient differentiation of functional hepatocytes from human embryonic stem cells. Stem Cells, 26, 1117–1127.PubMedCrossRefGoogle Scholar
  29. 29.
    Espejel, S., Roll, G. R., McLaughlin, K. J., et al. (2010). Induced pluripotent stem cell-derived hepatocytes have the functional and proliferative capabilities needed for liver regeneration in mice. The Journal of Clinical Investigation, 120, 3120–3126.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Samira Asgari
    • 1
    • 2
  • Mohsen Moslem
    • 1
  • Kamran Bagheri-Lankarani
    • 3
  • Behshad Pournasr
    • 1
  • Maryam Miryounesi
    • 1
  • Hossein Baharvand
    • 1
    • 4
    Email author
  1. 1.Department of Stem Cells and Developmental BiologyCell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECRTehranIran
  2. 2.Department of BiotechnologyCollege of Science, University of TehranTehranIran
  3. 3.Health Policy Research CenterShiraz University of Medical SciencesShirazIran
  4. 4.Department of Developmental BiologyUniversity of Science and Culture, ACECRTehranIran

Personalised recommendations